Discontinuation report CEFTIN - TAB 500MG
Report ID | 121049 |
Drug Identification Number | 02212285 |
Brand name | CEFTIN - TAB 500MG |
Common or Proper name | Cefuroxime axetil tablet |
Company Name | GLAXOSMITHKLINE INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | CEFUROXIME |
Strength(s) | 500MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | All pack sizes / Tous les formats |
ATC code | J01DC |
ATC description | OTHER BETA-LACTAM ANTIBACTERIALS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2020-07-20 |
Remaining supply date | 2018-11-30 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2020-07-24 | French | Compare |
v7 | 2020-07-24 | English | Compare |
v6 | 2020-07-24 | French | Compare |
v5 | 2020-07-24 | English | Compare |
v4 | 2020-07-24 | French | Compare |
v3 | 2020-07-24 | English | Compare |
v2 | 2020-07-24 | French | Compare |
v1 | 2020-07-24 | English | Compare |
Showing 1 to 8 of 8